Calamos Advisors’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-27,668
| Closed | -$2.31M | – | 949 |
|
|
2024
Q4 | $2.31M | Sell |
27,668
-3,952
| -12% | -$330K | 0.01% | 565 |
|
|
2024
Q3 | $2.31M | Buy |
31,620
+15,216
| +93% | +$1.11M | 0.01% | 571 |
|
|
2024
Q2 | $1.12M | Buy |
16,404
+7,590
| +86% | +$520K | 0.01% | 604 |
|
|
2024
Q1 | $610K | Buy |
8,814
+662
| +8% | +$45.8K | ﹤0.01% | 669 |
|
|
2023
Q4 | $584K | Buy |
+8,152
| New | +$584K | ﹤0.01% | 680 |
|
|
2022
Q3 | – | Sell |
-93,772
| Closed | -$5.35M | – | 1324 |
|
|
2022
Q2 | $5.35M | Sell |
93,772
-4,940
| -5% | -$282K | 0.02% | 642 |
|
|
2022
Q1 | $6.04M | Buy |
+98,712
| New | +$6.04M | 0.02% | 631 |
|